This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200305-690OCv1 169/1/20    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ali, F. R. Articles by Kay, A. B. Search for Related Content PubMed PubMed Citation Articles by Ali, F. R. Articles by Kay, A. B.

Late Asthmatic Reactions Induced by Inhalation of Allergen-derived T Cell Peptides

Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London, London, United Kingdom; and Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa, Japan

Correspondence and requests for reprints should be addressed to Prof. A. Barry Kay, Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK. E-mail: a.b.kay{at}imperial.ac.uk

In individuals with atopy and asthma, allergen-derived T cell peptides injected intradermally induce isolated late asthmatic reactions (LARs) followed by bronchial hyporesponsiveness to peptide, inhibition of the allergen-induced cutaneous late-phase reaction, and altered T cell function in vitro. Laboratory animal data indicate that "activation" and "tolerance" also occur if peptides are inhaled. In this study, we show that inhalation of Fel d 1–derived peptides induced isolated LAR in individuals with asthma sensitive to cat allergen comparable with that previously demonstrated using intradermal injection. LARs were accompanied by eosinophilia and nonsignificant elevations of total cysteinyl leukotrienes in the sputum. Unlike the intradermal route, repeated inhalation of peptides was not associated with abrogation of the LAR and produced a sputum eosinophilia comparable with the first exposure. In addition, there was no inhibition of the cutaneous late-phase reaction to whole cat dander. Thus, isolated LAR induced by inhaled, allergen-derived peptides represent a novel model of provoked asthma and are not associated with the induction of hyporesponsiveness ("tolerance") in the skin or lung.

Key Words: allergy • T lymphocytes • epitopes • inflammation • tolerance

This article has been cited by other articles:

				M. Larche Regulatory T Cells in Allergy and Asthma Chest, September 1, 2007; 132(3): 1007 - 1014. [Abstract] [Full Text] [PDF]

				F R. Ali, A B. Kay, and M. Larche Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects Thorax, September 1, 2007; 62(9): 750 - 757. [Abstract] [Full Text] [PDF]

				H. Jeal, A. Draper, J. Harris, A. N. Taylor, P. Cullinan, and M. Jones Modified Th2 Responses at High-Dose Exposures to Allergen: Using an Occupational Model Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 21 - 25. [Abstract] [Full Text] [PDF]

				A. B. Kay Natural killer T cells and asthma. N. Engl. J. Med., March 16, 2006; 354(11): 1186 - 1188. [Full Text] [PDF]

				L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698. [Full Text] [PDF]

				C. Pechlaner Patient Outcome of Invasive Experiments Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 1034 - 1034. [Full Text] [PDF]

				M. Larche, A. B. Kay, and L.-P. Boulet Peptide Therapy and Asthma Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1331 - 1332. [Full Text] [PDF]

				L.-P. Boulet Allergen-derived T Cell Peptides and Late Asthmatic Responses Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 2 - 3. [Full Text] [PDF]